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Guillain-Barre Syndrome (GBS) is an acute polyradiculoneuropathy 
characterized by progressive motor weakness of limbs and areflexia. In this 
study, our aim was to evaluate the clinical pattern and prognosis of children with 
Guillain-Barre syndrome.
Materials&Methods
This cross-sectional study was conducted in the Pediatric Neurology Unit of 
Amirkola Children’s Hospital, Babol, Iran during the period of 5 years from 
October 2008 to September 2013. We assessed the clinical features, results of 
electrodiagnostic tests, functional status, treatment and outcome of 17 children 
diagnosed with GBS.
Results
Of 17 (male to female ratio = 1.6:1) children studied, all had motor weakness, 
4 children (23.5 %) and cranial nerve palsies. Respiratory paralysis was found 
in one child requiring assisted ventilation. Antecedent illness preceding GBS 
was recorded in 7 (41.2%) children. The GBS subtype distribution as per 
electrodiagnostic studies was as follows: acute inflammatory demyelinating 
polyradiculoneuropathy (AIDP) in 12 (70.6%) acute motor axonal neuropathy 
(AMAN) in 3 (17.6%), acute motor sensory axonal neuropathy (AMSAN) in 2 
(11.8%). IVIG constituted the treatment given in all of the patients. Complete 
recovery was observed in 16 children and the remaining one child was dependent 
to wheelchair.
Conclusion
GBS in children is not poor prognostic disorder and our recommendation is 
administration of IVIG as soon as possible after clinical diagnosis. Except for 
one child who remained wheelchair bound, there was no mortality or morbidity 
in long-term observation. Besides, strong limitation of our study was the low 
number of subjects.
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Introduction 
Guillain-Barré syndrome (GBS) is an immune mediated polyradiculoneuropathy 
with an acute onset and a variable clinical course (1). It is also known as Landry’s 
paralysis and frequently preceded by an unspecified infection (2). This syndrome 
manifests as progressive areflexic or hyporeflexive motor paralysis with or without 
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admitted in our hospital and followed them four times 
(3, 6, 12, 24 months) after discharge. Eleven (64.7%) 
were male. Age of our patients on admission time ranged 
from 2 yr to 9 yr (4.4± 1.9). The history of antecedent 
illness was found in 7 subjects (41.2%) in the preceding 
two weeks. Of these antecedent illnesses, respiratory 
tract infection was found in 3 cases (42.9%), diarrhea 
in 2 cases (28.6%) and nonspecific febrile illness in 2 
children (28.6%). 
At admission, all 17 children presented with limb 
weakness. Cranial nerve palsy was observed in 4 (23.5%) 
children. Of which, 2 had bulbar palsy and 2 children 
had facial palsy. Respiratory insufficiency was found 
in one child requiring assisted ventilation. The GBS 
subtype distribution as per electrodiagnostic studies 
was as follows: acute inflammatory demyelinating 
polyradiculoneuropathy (AIDP) in 12 (70.6%), acute 
motor axonal neuropathy (AMAN) in 3 (17.6%) and 
acute motor sensory axonal neuropathy (AMSAN) 
in 2 (11.8%). NCV (nerve conduction velocity) was 
performed in all children at first 72 h of admission time 
except in one child intubated and NCV was done after 
extubation.  CSF analysis was performed in 11 children 
at 5-7th days of admission and the characteristic feature 
of albumin-cytological dissociation (<10 mononuclear 
cells) was observed in only two children. IVIG was 
administered to all patients (2 gm/kg) in five consecutive 
days. Physical therapy was ordered for all patients.
We followed all patients for long time. In first visit 
after about three months, 6 (35.3%) patients had normal 
neurologic examination. In second visit after about six 
months, 12 (70.6%) patients were normal. in third visit 
after about 12 months after discharging from the hospital, 
16 (94.1%) patients were normal and had complete motor 
function with normal deep tendon reflexes and only one 
child was wheelchair bound and finally in last visit after 
24 months (about 2 yr), our findings was similar to third 
visit. 
Discussion 
GBS is the most common cause of acute flaccid paralysis 
in infants and children. GBS could be seen in all age 
groups. We included, 17 cases of <10 yr of age (range 
2-9) and 41% of children were below 4 yr. In one study 
of 61 children younger than 15 yr of age with GBS, found 
sensory deficit. Weakness typically progress over hours 
to a few days (2). Autonomic dysfunction is common 
in GBS. Recovery period in this disorder is shorter in 
children than adults are and mortality rate in children is 
about 3-5% (1). Respiratory insufficiency is an ominous 
event in GBS and can lead to death in these patients. 
Besides, autonomic dysfunction is another main cause of 
mortality in affected children. (1, 3). Nerve conduction 
velocity (NCV) is performed to confirm this diagnosis. 
IVIG and plasma exchange have made a significant 
change in the course of the illness (4). 
We performed a cross sectional study on the natural 
history in children with GBS to study their clinical profile 
using intravenous immunoglobulin (IVIG) in addition to 
supportive management in long-term assessment (from 
2008 to 2014).
Materials & Methods
This cross-sectional study was conducted in the Pediatric 
Neurology Unit of Amirkola Children’s Hospital, Babol 
Medical University, Babol, Iran during the period of 
5 years from October 2008 to September 2013. The 
subjects of the study were children < 10 yr of age 
diagnosed with GBS. We assessed the clinical features, 
results of electro-diagnostic tests, functional status, 
treatment instituted and outcome. 
A complete neurological examination was conducted 
including examination of cranial nerves, motor system 
and sensory system as well as deep tendon reflexes. 
Electrodiagnostic study was done in all patients 
and electrophysiological subtypes of GBS were 
noted. CSF examination was performed in selected 
hemodynamically stable children. 
All children were treated with IVIG in a dose of 2 gm/kg 
over 2-5 d in addition to conventional supportive and/or 
intensive respiratory care. 
Statistical analysis was done using SPSS (Chicago, IL, 
USA) and numerical parametric data were presented as 
percentages. 
This study has been done with approval of the Ethics 
Committee of the Babol University of Medical Sciences. 
All patients’ children were taken informed consent form.
Results
We evaluated 17 children with documented GBS 
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that most of the children who had GBS were below 4 yr, 
and only one case was seen in the 10-15 yr age group (4). 
In our study, male: female ratio was 1.8:1. Dhadke et 
al., observed a male preponderance in their study with 
a male: female ratio of 1.5:1 (2). Maneesh Kumar et al., 
reported a male: female ratio of 2.3:1 (8). 
Two third of the cases will develop the neurological 
signs and symptoms within one to two weeks from the 
antecedent illness (8). In this study, history of antecedent 
illness was found in 7 subjects (41.2%) in the preceding 
two weeks. Dhadke et al., reported respiratory infections 
as the most common preceding disorder in their study, 
followed by gastrointestinal infection (2). All subjects in 
our study presented with limb weakness. Akbayram et 
al., reported limb weakness in 34/36(94.4%) of children 
with GBS (6). Cranial nerve palsy was observed in 4 
(23.5%) children. Loeffel et al., reported a 50% incidence 
of cranial nerve palsies in GBS, facial nerve being the 
commonest (7). Respiratory insufficiency was found 
in one child requiring assisted ventilation. Akbayram 
et al, reported respiratory insufficiency and assisted 
ventilation in 3/36 (8.3%) of children with GBS (6). In 
our study, the most common form of electrophysiologic 
form of GBS was AIDP (70.6%). Most of the pediatric 
patients in the study by Pi-Lien et al., belonged to the 
AIDP group (3). In Akbayram et al study, AIDP was 
the most common form (69.4%) (6). CSF analysis was 
performed in 11 children. Typical CSF finding of less 
than 10 mononuclear leukocytes/mm3 was found in 
only 2 cases. Albumino-cytological dissociation in 
CSF analysis (elevated CSF protein with less than 10 
mononuclear WBCs / mm3) was reported in 2 out of 5 
children in a recent study (8). 
Fortunately, we did not see any death due to GBS in 
our long-term follow up study, while  Akbayram et al, 
reported 8.3% deaths (3/36) (6). Our study was similar 
to Maneesh Kumar et al. study (8). (Table 1). 
Finally, complete recovery after last visit (after 24 months) 
was 16/17 (94.1%) in our study. In Korinthenberg et 
al study, complete recovery was 92% and in Maneesh 
Kumar et al. study was 82.4% (8, 9). 
In conclusion, GBS is not poor prognostic disorder in 
children, especially; we administered IVIG as soon as 
possible after clinical suspicion. Regardless of the severity 
of disease on admission time and electrophysiological 
subgroups, a majority achieved complete motor and 
sensory recovery. Strong limitation of our study was the 
low number of cases. Except for one child who remained 
wheelchair bound, there was no mortality or morbidity 
in long term observation. 
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Table 1. Comparison of Prognosis of Subjects with Other Two Studies in Terms of Number (Percent)













Total subjects 36 17 17
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